December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]
Judge Orders Dec. 21 Hearing in Suit to Block Huge Cuts to 340B Hospitals
November 28, 2017—A federal district judge has scheduled a Dec. 21 hearing in the lawsuit seeking to stop drastic Medicare Part B drug reimbursement cuts for many 340B hospitals from taking effect on Jan. 1. … [Read more...]
CMS Finalizes Nearly 30 Percent Cut in Medicare Part B Drug Payments to 340B Hospitals
November 1, 2017—The Centers for Medicare & Medicaid Services late today published a final Outpatient Prospective Payment System (OPPS) regulation that cuts Medicare Part B drug reimbursement to hospitals in the 340B drug discount program for separately payable drugs by nearly 30 percent, from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The reduction … [Read more...]
Senators to HHS: Start Enforcing 340B Manufacturer Penalties Rule
October 31, 2017—Thirteen U.S. Senators have asked the Department of Health and Human Services to stop delaying enforcement of a 340B drug discount program final rule to police drug manufacturer overcharging. “HHS has conducted several rounds of public comment and had more than seven years to consider” the 340B ceiling price and manufacturer civil monetary penalties final … [Read more...]
Hospitals Protest Decision to Delay Rule to Deter Drug Manufacturer Overcharging
September 28, 2017—Hospitals in the federal 340B drug discount program objected strongly today to the U.S. Department of Health and Human Services’ decision to delay enforcement of a critical 340B program rule to police drug manufacturer overcharging, from Oct. 1, 2017 to July 1, 2018. The hospitals say they also are troubled that HHS says it intends to engage in additional … [Read more...]
340B Health Urges HHS to Start Enforcing Regulation to Police Drug Industry Overcharging
September 20, 2017— The U.S. Department of Health and Human Services should not delay a long-overdue federal regulation to punish drug manufacturers that illegally overcharge safety-net hospitals and other healthcare providers for lifesaving medicines, thousands of safety-net providers enrolled in the federal 340B drug discount program said in written comments to HHS … [Read more...]
NPR and Kaiser Health News Explore 340B Orphan Drug Exclusion
September 18, 2017—National Public Radio and Kaiser Health News have collaborated on an in-depth report on how a federal law that denies rural hospitals 340B drug discounts on orphan drugs “has left rural hospital pharmacists and health care workers struggling to keep medicines in stock, and wondering if they will be able to adequately care for patients.” … [Read more...]